Literature DB >> 17603637

Hepatorenal syndrome.

Charles K F Ng1, Michael H M Chan, Morris H L Tai, Christopher W K Lam.   

Abstract

Hepatorenal syndrome (HRS) is a serious complication of liver cirrhosis with critically poor prognosis. The pathophysiological hallmark is severe renal vasoconstriction, resulting from complex changes in splanchnic and general circulations as well as systemic and renal vasoconstrictors and vasodilators. Rapid diagnosis and management are important, since recent treatment modalities including vasoconstrictor therapy can improve short-term outcome and buy time for liver transplantation, which can result in complete recovery.

Entities:  

Year:  2007        PMID: 17603637      PMCID: PMC1904420     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  49 in total

1.  Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225].

Authors:  Vicente Arroyo
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

2.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Authors:  Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul Cervoni; Philippe Ichaï; Armand Abergel; Chantal Halimi; Mathieu Pauwels; Jean-Pierre Bronowicki; Emile Giostra; Cathy Fleurot; Danielle Gurnot; Olivier Nouel; Philippe Renard; Michel Rivoal; Pierre Blanc; Dimitri Coumaros; Sylvie Ducloux; Stephane Levy; Alexandre Pariente; Jean-Marc Perarnau; Jean Roche; Myriam Scribe-Outtas; Dominique Valla; Brigitte Bernard; Didier Samuel; Joël Butel; Antoine Hadengue; Andrzej Platek; Didier Lebrec; Jean-Francois Cadranel
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.

Authors:  M Levy; M J Wexler
Journal:  Am J Physiol       Date:  1987-10

4.  Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.

Authors:  E T Schroeder; L Shear; S M Sancetta; G J Gabuzda
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

5.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

Review 6.  Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis.

Authors:  R W Schrier; M Niederberger; A Weigert; P Ginès
Journal:  Semin Liver Dis       Date:  1994-02       Impact factor: 6.115

7.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

Authors:  Isabelle Colle; François Durand; Fabienne Pessione; Emmanuel Rassiat; Jacques Bernuau; Eric Barrière; Didier Lebrec; Dominique-Charles Valla; Richard Moreau
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

9.  Hepatorenal syndrome without avid sodium retention.

Authors:  F J Dudley; G C Kanel; L J Wood; T B Reynolds
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

10.  Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites.

Authors:  A J Stanley; E H Forrest; K Dabos; I A Bouchier; P C Hayes
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  14 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

2.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

3.  Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.

Authors:  Mohd Talha Noor; Manish Tiwari; Ravindra Kumar
Journal:  Indian J Gastroenterol       Date:  2016-02-13

Review 4.  Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes.

Authors:  Konstantinos Makris; Loukia Spanou
Journal:  Clin Biochem Rev       Date:  2016-05

Review 5.  A narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient.

Authors:  Edgewood R Warner; Fuad Z Aloor; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

Review 6.  Acute kidney injury in children with chronic liver disease.

Authors:  Akash Deep; Romit Saxena; Bipin Jose
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

7.  Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients.

Authors:  Yau-Jiunn Lee; Chao-Ping Wang; Wei-Chin Hung; Wei-Hua Tang; Yu-Hung Chang; Der-Wei Hu; Yung-Chuan Lu; Teng-Hung Yu; Cheng-Ching Wu; Fu-Mei Chung; Chia-Chang Hsu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-17       Impact factor: 3.168

8.  Predictive Analytics for Care and Management of Patients With Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes.

Authors:  Jessica Qiuhua Sheng; Paul Jen-Hwa Hu; Xiao Liu; Ting-Shuo Huang; Yu Hsien Chen
Journal:  J Med Internet Res       Date:  2021-02-12       Impact factor: 5.428

9.  Nephrogenic systemic fibrosis risk and liver disease.

Authors:  Robert F Hanna; Lee A Finkelstone; Daniel S Chow; Vesselin Z Miloushev; Mark R Escudero; Stephen M Lagana; Martin R Prince
Journal:  Int J Nephrol       Date:  2014-03-23

10.  The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).

Authors:  Ellen R Berni; Bethan I Jones; Thomas R Berni; James Whitehouse; Mark Hudson; James Orr; Pete Conway; Bharat Amlani; Craig J Currie
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.